Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

All

News

Sport

Culture

Lifestyle

Alcoholics given semaglutide reduced alcohol consumption, had fewer heavy drinking days and saw a reduction in alcohol cravings (Getty Images)

A new Danish study indicates that semaglutide, marketed as Wegovy and Ozempic, could help individuals with alcohol problems by reducing consumption, heavy drinking days, and cravings.

The 26-week trial involved 108 obese patients diagnosed with alcohol use disorder, with half receiving 2.4mg of semaglutide and the other half a placebo, in addition to talking therapy.

Participants treated with semaglutide saw a significant decrease in heavy drinking days, dropping from an average of 17 to approximately five per month, while the placebo group reduced to nine days.

Overall alcohol consumption also reduced more substantially in the semaglutide group, decreasing from about 2,200g to 650g over a 30-day period, compared to…